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The recent article in CMI by Zahar et al. [1]
reported 45 cases of anaerobic bacteraemia in
cancer patients during a 6-year period. The
authors made the important point that, although
these infections occur infrequently, they can be
serious, and even fatal. The use of some antimi-
crobial agents, such as ceftazidime, as initial
monotherapy for fever does not provide coverage
for anaerobic bacteria. Delayed administration of
appropriate therapy, or inappropriate therapy,
results in substantially higher mortality rates.
A review of 451 episodes of anaerobic bacter-
aemia was conducted at the University of Texas
M. D. Anderson Cancer Center, covering the
period from 1972 to 1983 [2,3]. Apparently, many
physicians are not aware of this large review. The
large number of cases made it possible to analyse
clostridial infections separately from infections
caused by non-sporulating anaerobes, which is
important because some Clostridium spp., most
notably Clostridium perfringens and Clostridium
septicum, produce potent toxins that can cause
characteristic presentations.
The majority (70%) of the 451 infections were
caused by non-sporulating anaerobes, predomin-
antly Bacteroides spp., and especially Bacteroides
fragilis; C. perfringens and C. septicum were the
most common causes of clostridial infection. In
both groups, the most frequent underlying malig-
nancies were acute leukaemia, and genitourinary
and gastrointestinal malignancies. Polymicrobial
infection occurred in 27% of the cases. Among
patients with infections caused by non-sporulat-
ing organisms, 48% had abdominal abscesses,
28% had soft tissue infection and necrosis, and
28% presented with septic shock. Among patients
with clostridial infections, 38% had abdominal or
rectal abscesses, necrotic tumours or peritonitis,
44% had soft tissue infections (11% with necro-
sis), and 38% presented with septic shock. Occa-
sional patients with clostridial infections had gas
gangrene, disseminated crepitant skin lesions, or
acute haemolysis. C. septicum infections were
associated with typhlitis in neutropenic patients
with acute leukaemia.
The overall cure rates were 70% for patients
with non-sporulating anaerobic infections, and
58% for patients with clostridial infections. Cure
rates were lower in patients with septic shock,
pneumonia, polymicrobial infection, and persist-
ent severe neutropenia.
It is apparent from both the older and current
studies that, while they are not frequent, anaer-
obic infections are often serious and can be fatal if
not treated early with appropriate antimicrobial
agents. Hence, those patients with abdominal
symptoms, peri-rectal abscesses or necrotic skin
lesions, and especially those patients with under-
lying acute leukaemia, or genitourinary or
gastrointestinal malignancies, should receive
anaerobic coverage as part of their initial empir-
ical therapy.
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